Fraboulet, Severine
11  results:
Search for persons X
?
6

Outcome of Patients With Resected Early-Stage Non-small Cel..:

Mordant, Pierre ; Brosseau, Solenn ; Milleron, Bernard...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cllc.2022.08.013.  , 2023
 
?
7

Outcome of Patients With Resected Early-Stage Non-small Cel..:

Mordant, Pierre ; Brosseau, Solenn ; Milleron, Bernard...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cllc.2022.08.013.  , 2023
 
?
8

Outcome of Patients With Resected Early-Stage Non-small Cel..:

Mordant, Pierre ; Brosseau, Solenn ; Milleron, Bernard...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cllc.2022.08.013.  , 2023
 
?
9

Outcome of Patients With Resected Early-Stage Non-small Cel..:

Mordant, Pierre ; Brosseau, Solenn ; Milleron, Bernard...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cllc.2022.08.013.  , 2023
 
?
10

Nivolumab or nivolumab plus ipilimumab in patients with rel..:

Scherpereel, Arnaud ; Mazières, Julien ; Greillier, Laurent...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S1470-2045(18)30765-4.  , 2019
 
?
11

Nivolumab or nivolumab plus ipilimumab in patients with rel..:

Scherpereel, Arnaud ; Mazières, Julien ; Greillier, Laurent...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S1470-2045(18)30765-4.  , 2019
 
1-11